Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer-Reference-Cited by-同舟云学术

Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

Published:2007-07-11 Issue:7153 Volume:448 Page:561-566
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Soda Manabu,Choi Young Lim,Enomoto Munehiro,Takada Shuji,Yamashita Yoshihiro,Ishikawa Shunpei,Fujiwara Shin-ichiro,Watanabe Hideki,Kurashina Kentaro,Hatanaka Hisashi,Bando Masashi,Ohno Shoji,Ishikawa Yuichi,Aburatani Hiroyuki,Niki Toshiro,Sohara Yasunori,Sugiyama Yukihiko,Mano Hiroyuki

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature05945.pdf

Reference27 articles.

1. Jemal, A. et al. Cancer statistics, 2006. CA Cancer J. Clin. 56, 106–130 (2006)

2. Schiller, J. H. et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N. Engl. J. Med. 346, 92–98 (2002)

3. Lynch, T. J. et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med. 350, 2129–2139 (2004)

4. Paez, J. G. et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304, 1497–1500 (2004)

5. Druker, B. J. et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N. Engl. J. Med. 344, 1031–1037 (2001)

Cited by 4567 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the future of cancer diagnosis – promises and challenges of ctDNA-based liquid biopsies in non-small cell lung cancer;Translational Research;2024-10

2. Establishment of potential reference measurement procedure and reference materials for EML4-ALK fusion variants measurement;2024-09-10

3. New Benchmark for Targeted Therapies in Lung Cancer: Median Progression-Free Survival for Lorlatinib in Advanced ALK+ Non–Small Cell Lung Cancer Surpasses 5 years;Journal of Clinical Oncology;2024-09-04

4. A Review on Anaplastic Lymphoma Kinase (ALK) Rearrangements and Mutations: Implications for Gastric Carcinogenesis and Target Therapy;Current Protein & Peptide Science;2024-09

5. Sustainable nanomaterials for precision medicine in cancer therapy;Materials Today Sustainability;2024-09